Alvotech (ALVO) EPS (Basic) (2021 - 2026)
Alvotech's (ALVO) quarterly EPS (Basic) came in at -$0.23 in Q2 2026, down 359.71% on a YoY basis from $0.09 in Q2 2025, and down 7181.0% quarter-over-quarter from $0.0 in Q1 2026.
Analysis
Alvotech (ALVO) EPS (Basic) (2021 - 2026) Analysis & Trends
Alvotech (ALVO) has reported EPS (Basic) for 6 consecutive years, with -$0.23 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EPS (Basic) fell 359.71% year-over-year to -$0.23; the trailing twelve-month figure through Jun 2026 stood at -$0.96 (down 45.1% YoY), and the FY2025 full-year result was $0.84, up 211.36% from the prior year.
- EPS (Basic) declined to -$0.23 in Q2 2026 per ALVO's latest filing, from $0.0 in the prior quarter.
- Across five years, EPS (Basic) topped out at $3.66 in Q2 2022 and bottomed at -$5.33 in Q1 2022.
- Historically, EPS (Basic) has averaged -$0.88 across 5 years, with a median of -$0.49 in 2026.
- The widest YoY moves for EPS (Basic): up 129.0% in 2025, down 515.87% in 2025.
- Over 5 years, EPS (Basic) stood at -$2.88 in 2022, then declined by 4.53% to -$3.01 in 2023, then soared by 74.77% to -$0.76 in 2024, then jumped by 129.0% to $0.22 in 2025, then sank by 204.64% to -$0.23 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.23, $0.0, and $0.22 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.74 Bn | 39.09 Bn | 2.15 Bn | -0.49 |
| 2 | Viatris | 19.12 Bn | 18.23 Bn | 1.46 Bn | -0.10 |
| 3 | Dr Reddys Laboratories | 9.85 Bn | 9.68 Bn | 396.53 Mn | 0.06 |
| 4 | Amneal Pharmaceuticals | 5.47 Bn | 5.35 Bn | 334.51 Mn | 0.22 |
| 5 | Bausch Health Companies | 2.37 Bn | 530.13 Mn | 2.10 Bn | 0.69 |
| 6 | Alvotech | 1.51 Bn | 1.36 Bn | 2.56 Mn | -0.23 |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 1.17 |
| 8 | Amphastar Pharmaceuticals | 991.81 Mn | 701.69 Mn | 93.47 Mn | 0.70 |
| 9 | Fennec Pharmaceuticals | 412.12 Mn | 370.87 Mn | 17.15 Mn | 0.06 |
| 10 | RedHill Biopharma | 182.76 Mn | 182.76 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.23 |
| Mar 31, 2026 | 0.00 |
| Dec 31, 2025 | 0.22 |
| Sep 30, 2025 | -1.03 |
| Jun 30, 2025 | -0.05 |
| Mar 31, 2025 | 0.29 |
| Dec 31, 2024 | -0.76 |
| Sep 30, 2024 | -0.17 |
| Jun 30, 2024 | 0.39 |
| Mar 31, 2024 | -1.02 |
| Dec 31, 2023 | -3.01 |
| Aug 31, 2023 | -0.94 |
| Jun 30, 2023 | 0.75 |
| Mar 20, 2023 | -3.80 |
| Dec 31, 2022 | -2.88 |
| Aug 31, 2022 | -1.98 |
| Jun 30, 2022 | 3.66 |
| Mar 20, 2022 | -5.33 |
| Dec 31, 2021 | -1.35 |
| Sep 30, 2021 | -1.34 |